← back to search

Yuanji Xu

Guangzhou University of Chinese Medicine · CN
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Medicine, Radiation therapy, Oncology, Internal medicine, Cervical cancer, and Esophageal cancer.
h-index
citations
358
works
16
NIH funding
primary concept
email

Recent publications

Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A)
BMC Cancer 2025cited by 3position: firstdoi
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)
Frontiers in Immunology 2025cited by 0position: middledoi
WITHDRAWN: 2143P Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: A multicenter, real-world, retrospective cohort study from China
Annals of Oncology 2025cited by 0position: middledoi
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study
Cancer Immunology Immunotherapy 2025cited by 0position: middledoi
High-Dose Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer: A Multicenter Real-World Study with Dose-Benefit Exploration
Research Square 2025cited by 0position: middledoi
Efficacy of internet-based peer education for postpartum depression: study protocol of a randomized controlled trial
Frontiers in Public Health 2025cited by 0position: middledoi
Correction: Efficacy of internet-based peer education for postpartum depression: study protocol of a randomized controlled trial
Frontiers in Public Health 2025cited by 0position: middledoi
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study
Therapeutic Advances in Medical Oncology 2024cited by 3position: middledoi
Dose escalation in radical radio(chemo)therapy for cervical and upper thoracic esophageal cancer with 3DCRT/IMRT (ChC&UES): a multicenter retrospective study
Radiation Oncology 2024cited by 3position: middledoi
Dose Escalation in Radical Radio(chemo)therapy for Cervical and Upper Thoracic Esophageal Cancer with 3DCRT/IMRT (ChC&UES): A Multi-center Real world Study
Research Square 2024cited by 0position: middledoi
Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma
JAMA Network Open 2023cited by 27position: middledoi
Identification and Validation of a Prognostic Signature of m 5 C-Related Genes for Esophageal Cancer
Research Square 2023cited by 0position: lastdoi
A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy
Radiation Oncology 2020cited by 33position: middledoi
[A multicenter randomized prospective study of concurrent chemoradiation with 60 Gy versus 50 Gy for inoperable esophageal squamous cell carcinoma].
PubMed 2020cited by 8position: firstdoi
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
Annals of Oncology 2017cited by 193position: middledoi
A Comparison Between the Chinese 2008 and the 7th Edition AJCC Staging Systems for Nasopharyngeal Carcinoma
American Journal of Clinical Oncology 2013cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenbin Shen · Henan Institute of Technology6 papers (2023–2025)Junqiang Chen · Shandong University6 papers (2024–2025)Yatian Liu · Hebei Medical University4 papers (2024–2025)Kuaile Zhao · Shanghai Medical College of Fudan University4 papers (2024–2025)Xiaojie Xia · Jiangsu University3 papers (2024–2025)Chunyue Gai · Hebei Medical University3 papers (2024–2025)Xin Wang · China University of Mining and Technology3 papers (2024–2025)Honglei Luo · Nanjing Medical University3 papers (2024–2025)Pu-Dong Qian · Nanjing Medical University3 papers (2024–2025)Wei Huang · Nanchang University3 papers (2024–2025)Xiaolin Ge · Nanjing Medical University3 papers (2024–2025)Xiao‐Han Zhao · Shihezi University3 papers (2024–2025)Wenyang Liu · University of Shanghai for Science and Technology2 papers (2024–2025)Xiao‐Bing Zheng · Guangzhou University of Chinese Medicine2 papers (2025–2025)J. F. Qiu · Guangzhou University of Chinese Medicine2 papers (2025–2025) · 2 papers (2024–2025)Shaojun Chen · Guangzhou University of Chinese Medicine2 papers (2025–2025)Yingying Zhang · Guangzhou University of Chinese Medicine2 papers (2024–2025)Yumei Zhou · Guangzhou University of Chinese Medicine2 papers (2025–2025)Xiaoyi Chen · Guangzhou University of Chinese Medicine2 papers (2025–2025)